SANGAMO THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SANGAMO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $178.00K.
- SANGAMO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-12-31 was $0.00.
- SANGAMO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $120.00K.
- SANGAMO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $224.00K, a 215.49% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $344.00K, a 384.51% increase from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $71.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-03-31 | $178.00K 10-Q · filed 2026-05-14 | $522.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $344.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $120.00K 10-Q · filed 2025-11-06 | $344.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $224.00K 10-Q · filed 2025-08-07 | $224.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-03-30 | $71.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $71.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $71.00K 10-Q · filed 2025-08-07 |